JAK kinases overexpression promotes in vitro cell transformation (Q40079753)

17 September 2017

JAK kinases overexpression promotes in vitro cell transformation (English)

1 reference

17 September 2017

1 reference

Stefan N Constantinescu

4

1 reference

17 September 2017

L Knoops

1

1 reference

17 September 2017

T Hornakova

2

1 reference

17 September 2017

Y Royer

3

1 reference

17 September 2017

J-C Renauld

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

17 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

27

1 reference

17 September 2017

11

1 reference

17 September 2017

1511-1519

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210800

17 September 2017

0 references

cites work

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Signaling through the JAK/STAT pathway, recent advances and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

IL-9 and its receptor: from signal transduction to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

STAT3 is constitutively activated in Hodgkin cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Generation of mammalian cells stably expressing multiple genes at predetermined levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

1 reference

7 January 2021

Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210800

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210800

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference